Chemicals · Founded 1960 · www.dai-ichiindia.com · BSE 526821 · NSE DAI-ICHI KAR · ISIN INE928C01010
No Notes Added Yet
Business
Dai-Ichi Karkaria Ltd. is an Indian manufacturer of specialty chemicals. The company's core business involves the production and supply of a diverse range of chemical auxiliaries, performance chemicals, and process chemicals. They focus on delivering customized solutions and performance enhancers rather than commodity chemicals. Their products are essential inputs for various industries, including textiles, leather, construction, oil & gas exploration, paints & coatings, personal care, agriculture, paper, and water treatment. The company makes money by developing, manufacturing, and selling these specialty chemicals to industrial clients based on their specific application requirements.
Revenue Mix
The company operates primarily within the specialty chemicals sector, with a broad product portfolio serving multiple end-user industries. While specific revenue breakdowns by segment are not typically disclosed for companies of this size, their product categories broadly include:
Textile Auxiliaries: Used in various stages of textile processing.
Oilfield Chemicals: Essential for drilling, cementing, and production in the oil & gas industry.
Construction Chemicals: Additives for concrete, mortars, and other building materials.
Agrochemical Formulations: Ingredients for agricultural products.
Surfactants & Emulsifiers: Used across diverse industries like personal care, cleaning, and industrial processes.
Polymers & Specialty Additives: For applications in various manufacturing processes.
This diversified application base suggests a relatively balanced revenue mix across these industrial applications, reducing over-reliance on a single sector.
Industry
Dai-Ichi Karkaria Ltd. operates in the Indian specialty chemicals industry, which is characterized by high growth potential, increasing technical complexity, and a focus on R&D. The industry is fragmented, with numerous domestic players and competition from global giants. Dai-Ichi Karkaria is an established player with over six decades of experience, positioning itself as a reliable supplier with technical expertise and a broad product range. They typically compete on product performance, customization capabilities, and customer service rather than pure price, distinguishing themselves from commodity chemical producers. Their long history provides an advantage in terms of brand recognition and established customer relationships within their niche segments.
MOAT
Dai-Ichi Karkaria's competitive advantages primarily stem from:
Technical Expertise & R&D: A long history and focus on specialty chemicals, combined with in-house R&D capabilities, allows them to develop tailored solutions and maintain product relevance. This helps in customer stickiness for specific applications.
Diversified Product Portfolio & Applications: Their wide range of products across numerous industries provides resilience against downturns in any single sector and offers cross-selling opportunities.
Established Customer Relationships: Decades of operation have led to strong, long-term relationships with industrial clients, who often rely on their consistent product quality and technical support.
Knowledge-Intensive Business: Specialty chemicals require significant know-how in formulation and application, creating a barrier to entry for new players compared to commodity chemicals.
Growth Drivers
Key factors that can drive growth for Dai-Ichi Karkaria over the next 3-5 years include:
Growth in End-User Industries: Continued expansion of key client sectors like textiles, construction, oil & gas, and agriculture in India will directly translate into increased demand for their specialty chemicals.
Rising Demand for Performance Chemicals: As industries seek greater efficiency, sustainability, and specific performance attributes, the demand for specialty chemicals over commodity chemicals will continue to grow.
Import Substitution: Government initiatives and a focus on domestic manufacturing ("Make in India") could boost demand for locally produced specialty chemicals.
Product Innovation & Expansion: Development of new products, entry into emerging application areas, and expansion of existing product capacities can open new revenue streams.
Increased R&D Investment: Continuous investment in research and development to offer advanced and customized solutions can drive market share.
Risks
Raw Material Price Volatility: A significant portion of specialty chemicals rely on petrochemical derivatives. Fluctuations in crude oil prices and other key raw materials can impact production costs and gross margins.
Intense Competition: The specialty chemicals market in India is competitive, with both larger domestic players and multinational corporations, as well as smaller unorganized players, vying for market share.
Regulatory Changes: Environmental regulations, safety standards, and chemical handling norms are evolving and can necessitate costly compliance measures or restrict operations.
Economic Downturns: A slowdown in the Indian or global economy can reduce demand from key end-user industries, impacting sales and profitability.
Technological Obsolescence: The need for continuous R&D to stay competitive and avoid product obsolescence requires consistent investment and can be a financial strain.
Management & Ownership
Dai-Ichi Karkaria Ltd. has a history rooted in a joint venture with a Japanese company and has been promoter-driven by the Karkaria family for a significant period. The Karkaria family continues to be involved in the management and holds a substantial ownership stake, aligning their interests with long-term company performance. The management team likely possesses deep industry experience and technical knowledge, which is critical in the specialty chemicals sector. The ownership structure generally features a strong promoter holding, with the remaining shares held by institutional investors and the public.
Outlook
Dai-Ichi Karkaria is positioned in a growing and strategically important sector of the Indian economy. Its long history, diversified product portfolio, and technical expertise provide a strong foundation. The company stands to benefit from the expansion of various manufacturing and service industries in India that require specialty chemical inputs. However, its performance is subject to the inherent volatility of raw material prices and intense competition. While its specialized niche and established customer relationships offer resilience, sustained growth will depend on continuous innovation, efficient cost management, and the ability to adapt to evolving industrial demands and regulatory landscapes. The outlook is balanced, acknowledging both its entrenched market position and the dynamic challenges of the chemical industry.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 33 | 34 | 37 | 41 | 70 | 39 | 43 | 38 | 41 | 58 |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| Total Income | 35 | 35 | 38 | 42 | 71 | 40 | 44 | 39 | 42 | 59 |
| Total Expenditure | 31 | 32 | 35 | 38 | 62 | 38 | 41 | 38 | 41 | 52 |
| Operating Profit | 4 | 3 | 3 | 4 | 9 | 2 | 3 | 1 | 2 | 7 |
| Interest | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 2 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit Before Tax | 1 | -0 | -0 | 3 | 7 | -1 | 1 | -2 | -1 | 4 |
| Provision for Tax | 0 | -0 | 0 | 1 | 2 | -0 | 1 | -1 | -0 | 2 |
| Profit After Tax | 1 | -0 | -0 | 2 | 5 | -1 | -0 | -2 | -1 | 2 |
| Adjustments | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
| Profit After Adjustments | 1 | 0 | -0 | 3 | 6 | 0 | 0 | -1 | 0 | 3 |
| Adjusted Earnings Per Share | 1.5 | 0.6 | -0.3 | 3.5 | 8.3 | 0 | 0 | -1.2 | 0.1 | 3.9 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 194 | 126 | 147 | 92 | 107 | 97 | 122 | 184 | 132 | 181 | 161 | 180 |
| Other Income | 4 | 12 | 6 | 3 | 4 | 5 | 4 | 6 | 4 | 4 | 5 | 5 |
| Total Income | 198 | 138 | 153 | 96 | 111 | 102 | 126 | 190 | 135 | 186 | 166 | 184 |
| Total Expenditure | 162 | 109 | 132 | 103 | 112 | 111 | 140 | 168 | 125 | 167 | 158 | 172 |
| Operating Profit | 37 | 30 | 21 | -8 | -1 | -9 | -14 | 22 | 10 | 19 | 8 | 13 |
| Interest | 1 | 0 | 0 | 7 | 10 | 9 | 1 | 3 | 3 | 2 | 1 | 0 |
| Depreciation | 2 | 2 | 4 | 8 | 9 | 9 | 7 | 7 | 9 | 10 | 10 | 12 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -1 | -4 | 82 | 4 | 10 | 21 | 2 | -0 | 0 |
| Profit Before Tax | 34 | 27 | 16 | -24 | -25 | 56 | -18 | 22 | 18 | 8 | -3 | 2 |
| Provision for Tax | 12 | 7 | 4 | -12 | 0 | 7 | 0 | 4 | 5 | 2 | 0 | 2 |
| Profit After Tax | 22 | 21 | 12 | -13 | -25 | 48 | -18 | 18 | 13 | 6 | -3 | -1 |
| Adjustments | -0 | 4 | 2 | 0 | 2 | 2 | 0 | 2 | 0 | 3 | 3 | 3 |
| Profit After Adjustments | 22 | 25 | 14 | -13 | -23 | 51 | -18 | 20 | 14 | 9 | -1 | 2 |
| Adjusted Earnings Per Share | 29.3 | 33.4 | 18.3 | -16.9 | -30.8 | 68 | -24.2 | 26.9 | 18.7 | 12.1 | -1 | 2.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -11% | -4% | 11% | -2% |
| Operating Profit CAGR | -58% | -29% | 0% | -14% |
| PAT CAGR | -150% | NAN% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 13% | -10% | -6% | -5% |
| ROE Average | -2% | 3% | 2% | 5% |
| ROCE Average | -1% | 5% | 4% | 9% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 126 | 150 | 159 | 143 | 120 | 170 | 150 | 170 | 181 | 188 | 185 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 1 | 4 | 60 | 73 | 68 | 0 | 4 | 17 | 1 | 0 | 0 |
| Other Non-Current Liabilities | 26 | 2 | 38 | 26 | 27 | 35 | 35 | -4 | 16 | 19 | 14 |
| Total Current Liabilities | 30 | 23 | 54 | 64 | 80 | 66 | 58 | 58 | 39 | 42 | 36 |
| Total Liabilities | 184 | 179 | 311 | 306 | 295 | 272 | 247 | 241 | 237 | 249 | 234 |
| Fixed Assets | 17 | 20 | 94 | 164 | 153 | 105 | 105 | 139 | 132 | 125 | 122 |
| Other Non-Current Assets | 61 | 68 | 118 | 70 | 68 | 75 | 73 | 33 | 53 | 53 | 48 |
| Total Current Assets | 106 | 91 | 100 | 72 | 74 | 93 | 67 | 68 | 53 | 70 | 65 |
| Total Assets | 184 | 179 | 311 | 306 | 295 | 272 | 247 | 241 | 237 | 249 | 234 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 7 | 4 | 2 | 4 | 5 | 1 | 12 | 2 | 6 | 6 | 9 |
| Cash Flow from Operating Activities | 11 | 3 | -8 | 6 | 1 | -22 | -3 | 23 | 10 | 16 | 5 |
| Cash Flow from Investing Activities | -8 | -7 | -57 | -21 | 1 | 130 | -4 | -33 | 16 | -4 | -10 |
| Cash Flow from Financing Activities | -6 | 2 | 66 | 16 | -6 | -97 | -2 | 13 | -25 | -10 | -3 |
| Net Cash Inflow / Outflow | -3 | -2 | 2 | 2 | -4 | 11 | -10 | 4 | 1 | 3 | -8 |
| Closing Cash & Cash Equivalent | 4 | 2 | 4 | 5 | 1 | 12 | 2 | 6 | 6 | 9 | 1 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 29.34 | 33.44 | 18.32 | -16.93 | -30.77 | 68.03 | -24.2 | 26.94 | 18.66 | 12.11 | -0.99 |
| CEPS(Rs) | 32.45 | 30.75 | 22.08 | -6.04 | -20.78 | 76.44 | -15.4 | 34.78 | 30.5 | 21.92 | 9.25 |
| DPS(Rs) | 3 | 3 | 2.5 | 0 | 0 | 3 | 0 | 4 | 2 | 3.5 | 1.5 |
| Book NAV/Share(Rs) | 164.93 | 201.17 | 213.19 | 191.54 | 160.6 | 228.82 | 201.21 | 228.05 | 242.63 | 252.56 | 247.83 |
| Core EBITDA Margin(%) | 15.96 | 13.03 | 10.25 | -11.62 | -4.7 | -13.84 | -14.92 | 8.68 | 4.76 | 7.94 | 2.13 |
| EBIT Margin(%) | 16.95 | 20.59 | 11.12 | -18.42 | -13.64 | 66.42 | -13.63 | 13.75 | 16.18 | 5.66 | -1.37 |
| Pre Tax Margin(%) | 16.56 | 20.52 | 10.99 | -26.21 | -23.14 | 57.03 | -14.84 | 12.09 | 13.87 | 4.65 | -1.95 |
| PAT Margin (%) | 10.8 | 15.59 | 8.04 | -13.59 | -23.14 | 49.48 | -14.84 | 10.1 | 10.19 | 3.4 | -2 |
| Cash Profit Margin (%) | 11.94 | 17.1 | 11.04 | -4.84 | -14.37 | 58.17 | -9.32 | 14.17 | 17.15 | 8.97 | 4.25 |
| ROA(%) | 12.46 | 11.5 | 4.88 | -4.09 | -8.3 | 17.09 | -7.04 | 7.58 | 5.65 | 2.54 | -1.34 |
| ROE(%) | 19.21 | 15.32 | 7.76 | -8.38 | -19.01 | 33.39 | -11.41 | 11.55 | 7.69 | 3.35 | -1.74 |
| ROCE(%) | 29.83 | 19.85 | 8.51 | -7.1 | -6.2 | 31.07 | -9.26 | 13.25 | 10.51 | 5.14 | -1.11 |
| Receivable days | 67.19 | 78.28 | 62.21 | 91.91 | 62.54 | 82.38 | 61.38 | 44.27 | 67.76 | 52.39 | 68.75 |
| Inventory Days | 29.24 | 43.9 | 43.59 | 71.41 | 63.41 | 83.63 | 70.1 | 41.9 | 49.37 | 35.94 | 44.04 |
| Payable days | 88.1 | 95.23 | 68.94 | 125.95 | 129.66 | 182.69 | 140.31 | 89.16 | 102.56 | 62.67 | 71.86 |
| PER(x) | 11.9 | 14.84 | 21.61 | 0 | 0 | 4.38 | 0 | 13.44 | 27.36 | 19.67 | 0 |
| Price/Book(x) | 2.12 | 2.47 | 1.86 | 1.07 | 1.09 | 1.3 | 1.82 | 1.59 | 2.1 | 0.94 | 0.9 |
| Dividend Yield(%) | 0.86 | 0.6 | 0.63 | 0 | 0 | 1.01 | 0 | 1.11 | 0.39 | 1.47 | 0.67 |
| EV/Net Sales(x) | 1.3 | 2.93 | 2.48 | 2.7 | 2.19 | 2.33 | 2.37 | 1.63 | 2.99 | 0.99 | 1.09 |
| EV/Core EBITDA(x) | 6.88 | 12.45 | 17.33 | -33.06 | -189.49 | -26.34 | -20.62 | 13.42 | 39.01 | 9.5 | 21.7 |
| Net Sales Growth(%) | 7.09 | -35 | 16.6 | -37.13 | 16.05 | -9.1 | 25.07 | 50.97 | -28.47 | 37.85 | -11.07 |
| EBIT Growth(%) | 4.49 | -19.58 | -39.94 | -203.32 | 14.14 | 542.38 | -125.8 | 249.88 | -14.79 | -51.94 | -121.55 |
| PAT Growth(%) | -6.1 | -4.45 | -42.65 | -205.43 | -97.47 | 294.23 | -137.72 | 201.09 | -26.96 | -54.19 | -152.43 |
| EPS Growth(%) | -6.1 | 13.96 | -45.2 | -192.38 | -81.76 | 321.12 | -135.58 | 211.31 | -30.74 | -35.11 | -108.2 |
| Debt/Equity(x) | 0.01 | 0.03 | 0.48 | 0.73 | 0.91 | 0.12 | 0.14 | 0.22 | 0.1 | 0.07 | 0.07 |
| Current Ratio(x) | 3.47 | 3.91 | 1.84 | 1.13 | 0.92 | 1.4 | 1.17 | 1.19 | 1.37 | 1.69 | 1.79 |
| Quick Ratio(x) | 2.95 | 3.21 | 1.49 | 0.86 | 0.67 | 1.04 | 0.77 | 0.85 | 0.94 | 1.23 | 1.24 |
| Interest Cover(x) | 43.62 | 275.9 | 82.85 | -2.36 | -1.44 | 7.07 | -11.26 | 8.27 | 7 | 5.63 | -2.34 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.26 | 0.68 | 0.83 | 0.09 | 0.08 | 0.14 | 0.05 | 0.07 | 0.08 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.88 | 63.88 | 63.92 | 63.98 | 63.98 | 63.98 | 63.98 | 63.98 | 63.98 | 63.98 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 36.12 | 36.12 | 36.08 | 36.02 | 36.02 | 36.02 | 36.02 | 36.02 | 36.02 | 36.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -11% | -4% | +11% | -2% |
| Operating Profit CAGR | -58% | -29% | — | -14% |
| PAT CAGR | -150% | 0% | 0% | 0% |
| Share Price CAGR | +13% | -10% | -6% | -5% |
| ROE Average | -2% | +3% | +2% | +5% |
| ROCE Average | -1% | +5% | +4% | +9% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.88 | 63.88 | 63.92 | 63.98 | 63.98 | 63.98 | 63.98 | 63.98 | 63.98 | 63.98 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 36.12 | 36.12 | 36.08 | 36.02 | 36.02 | 36.02 | 36.02 | 36.02 | 36.02 | 36.02 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 | 0.27 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 | 0.75 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.